Compare ODV & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ODV | OMDA |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Nursing Services |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 874.4M |
| IPO Year | N/A | 2025 |
| Metric | ODV | OMDA |
|---|---|---|
| Price | $3.58 | $15.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $26.44 |
| AVG Volume (30 Days) | ★ 1.4M | 1.3M |
| Earning Date | 11-10-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $8,089,655.00 | ★ $232,342,000.00 |
| Revenue This Year | $137.02 | $52.16 |
| Revenue Next Year | $76.30 | $22.43 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 89.23 |
| 52 Week Low | $1.16 | $14.14 |
| 52 Week High | $4.21 | $28.40 |
| Indicator | ODV | OMDA |
|---|---|---|
| Relative Strength Index (RSI) | 49.40 | N/A |
| Support Level | $3.39 | N/A |
| Resistance Level | $3.75 | N/A |
| Average True Range (ATR) | 0.22 | 0.00 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 22.46 | 0.00 |
Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration, and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico, and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation, and development activities of its projects.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.